tiprankstipranks
Trending News
More News >
Atara Biotherapeutics (ATRA)
NASDAQ:ATRA
US Market
Advertisement

Atara Biotherapeutics (ATRA) Financial Statements

Compare
1,159 Followers

Atara Biotherapeutics Financial Overview

Atara Biotherapeutics's market cap is currently $109.77M. The company's EPS TTM is $0.19; its P/E ratio is ―; Atara Biotherapeutics is scheduled to report earnings on August 11, 2025, and the estimated EPS forecast is $-0.67. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Currency in USD

Atara Biotherapeutics Earnings and Revenue History

Atara Biotherapeutics Debt to Assets

Atara Biotherapeutics Cash Flow

Atara Biotherapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis